1. Use standard diagnostic language

    The outcomes “correct upstaging” (i.e. avoiding stage-inappropriate surgery) and “incorrect upstaging” (i.e. precluding potential curative surgery) are arguably of equal importance and must be traded of against each other. The authors’ missed to present their findings in standard diagnostic language, i.e. using sensitivity, specificity (these do not depend on prevalence), predictive values (these depend on prevalence) etc. Moreover, their calculation of the “proportion of patients with correctly upstaged disease” (Table 2) does not take into account the difference in prevalence between the randomly allocated groups (28.7% vs. 36.4%) and, thus, hinders valid comparison. As a matter of fact, conventional staging yielded a much higher odds ratio (measuring association) than PET-CT staging (23.4 vs. 12.8, see Table B). While PET-CT staging is better in predicting curative surgery (i.e. the negative predictive value is higher, 81.6% vs. 68.0%), conventional staging is better in predicting stage-inappropriate surgery (i.e. the positive predictive value is higher, 91.7% vs. 74.2%). Albeit, these differences in predicted values become smaller when the difference in prevalence is accounted for (i.e. 81.6% vs. 75.1% and 88.6% vs. 74.2%, based on a prevalence of 28.7%). Would Maziak et al. please comment on this? Thanks.

    Table A: Absolute numbers extracted from study flow diagram (Figure 1, p. 224).

     

     

    Reference

     

     

     

    IIIB, IV

    < IIIB

    Sum

    PET-CT
    staging

    IIIB, IV

    23

    8

    31

    < IIIB

    25

    111

    136

     

    Sum

    48

    119

    167

     

    Conventional
    staging

    IIIB, IV

    11

    1

    12

    < IIIB

    48

    102

    150

     

    Sum

    59

    103

    162

     

    Table B: Characteristics of staging procedures (based on Table A).

     

    PET-CT staging

    Conventional staging

     

    Estimate

    95% CI*

    Estimate

    95% CI

    Prevalence

    0.287 (=48/167)

    0.224 to 0.360

    0.364 (=59/162)

    0.294 to 0.441

    Sensitivity

    0.479 (=23/48)

    0.345 to 0.617

    0.186 (=11/59)

    0.107 to 0.304

    Specificity

    0.933 (=111/119)

    0.873 to 0.966

    0.990 (=102/103)

    0.947 to 0.998

    Positive predictive value

    0.742 (=23/31)

    0.568 to 0.863

    0.917 (=11/12)

    0.646 to 0.985

    Negative predictive value

    0.816 (=111/136)

    0.743 to 0.872

    0.680 (=102/150)

    0.602 to 0.749

    Likelihood ratio, positive

    7.128 [=(23/48)/(8/119)]

    3.430 to 14.811

    19.203 [=(11/59)/(1/103)]

    2.542 to 145.049

    Likelihood ratio, negative

    0.558 [=(25/48)/(111/119)]

    0.424 to 0.736

    0.822 [=(48/59)/(102/103)]

    0.726 to 0.930

    Odds ratio

    12.765 [=(23*111)/(8*25)]

    5.117 to 31.841

    23.375 [=(11*102)/(1*48)]

    2.933 to 186.302

    * Confidence intervals were calculated using the software CIA 2.1.1, Trevor Bryant, © 2000, University of Southampton, UK.

    Conflict of Interest:

    None declared

    Submit response
  2. If the objective of the study had been little different

    Interpretation of PET images is improved by visual correlation with CT.PET/CT have been found useful in improving the accuracy of staging and restaging of lung cancers.But since Morikawa and colleagues' study have demonstrated that 18F-fluoro-2-deoxy-D-glucose(FDG)PET/CT combined with short-tau-inversion-recovery(STIR)MRI improved diagnostic capability for N -staging of lung cancer,wouldn't it have been better if you have used STIR MRI also as a diagnostic tool in your study design?MRI has a better image resolution than CT scan so why not combine PET with MRI than PET with CT scan?

    REFERENCES:

    1.Vansteenkiste,Johan F.MD,PhD;Stroobants,Sigrid s.MD,PhD.PET scan in lung cancer:current recommendations and innovation.Journal of Thoracic Oncology:January 2006-vol.1,Issue 1:71-73

    2.Morikawa M,Demura Y,Ishizaki T,et al.The Effectiveness of 18 F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the Thorax.J Nucl Med.2009;50:81-87

    Conflict of Interest:

    None declared

    Submit response
« Parent articleTable of Contents